An update on AMG 330: can BiTEs be as successful in AML as ALL? VJHemOnc – Video Journal of Hematology & HemOnc 1:57 6 years ago 213 Далее Скачать
Phase I study of AMG-330: a BiTe for R/R AML patients VJHemOnc – Video Journal of Hematology & HemOnc 5:19 4 years ago 58 Далее Скачать
BiTES for the treatment of acute myeloid leukemia (AML) - results with AMG 330 in ex vivo study VJHemOnc – Video Journal of Hematology & HemOnc 1:44 7 years ago 565 Далее Скачать
Update on AMG 330 bispecific for R/R AML VJHemOnc – Video Journal of Hematology & HemOnc 1:38 5 years ago 220 Далее Скачать
Findings For the BiTE Antibody AMG 330 in Relapsed/Refractory AML OncLive 1:40 6 years ago 255 Далее Скачать
Updates from AMG 330 in AML VJHemOnc – Video Journal of Hematology & HemOnc 4:16 4 years ago 96 Далее Скачать
AMG 330: an anti-CD33 bispecific T-Cell engager antibody construct in relapsed/refractory AML ecancer 3:35 6 years ago 307 Далее Скачать
Rationale for Phase I Study of AMG 330 in Relapsed/Refractory AML Targeted Oncology 1:26 6 years ago 86 Далее Скачать
An update on the state-of-affairs of BiTEs in the world of AML VJHemOnc – Video Journal of Hematology & HemOnc 1:21 6 years ago 118 Далее Скачать
Safety and tolerability of AMG 330, a bispecific T-cell engager, in adult patients with R/R AML VJHemOnc – Video Journal of Hematology & HemOnc 1:20 6 months ago 70 Далее Скачать
Exciting immunotherapy clinical trials for the management of AML VJHemOnc – Video Journal of Hematology & HemOnc 1:24 6 years ago 307 Далее Скачать
BiTE® Immunotherapy: The Next Generation of Cancer Treatment Amgen 3:36 6 years ago 21 138 Далее Скачать
Harnessing T-cells in acute leukemia and an anti-CD33/CD3 BiTE antibody VJHemOnc – Video Journal of Hematology & HemOnc 1:42 6 years ago 376 Далее Скачать
AMG 673: novel half-life extended anti-CD33/CD3 BiTE in R/R AML VJHemOnc – Video Journal of Hematology & HemOnc 2:23 5 years ago 334 Далее Скачать
Antibodies for AML: updates from ASH VJHemOnc – Video Journal of Hematology & HemOnc 1:40 6 years ago 42 Далее Скачать
What is treatment-related acute myeloid leukemia (AML), or tAML? You and AML 1:52 5 years ago 575 Далее Скачать
The challenges of choosing the right target antigen in AML compared to ALL VJHemOnc – Video Journal of Hematology & HemOnc 1:48 6 years ago 127 Далее Скачать
ISAL 2023: meeting highlights VJHemOnc – Video Journal of Hematology & HemOnc 1:19 1 year ago 193 Далее Скачать
Antibody-based therapy in AML: immunotoxins and BiTEs VJHemOnc – Video Journal of Hematology & HemOnc 3:50 3 years ago 111 Далее Скачать
T-Cell engaging treatment in AML VJHemOnc – Video Journal of Hematology & HemOnc 2:43 7 years ago 538 Далее Скачать
